SCHEMBL21769520

SCHEMBL21769520

Cc1cccc2cc(Cn3nc(-c4cccc(Cl)c4)c4c(I)ncnc43)n(-c3ccccc3F)c(=O)c12

nearest known ligand 0.83

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ PIK3CG P48736 6/20 0.83
▸ PIK3CD O00329 17/20 0.58
▸ PIK3CA P42336 6/20 0.47
▸ PIK3CB P42338 5/20 0.47
▸ ABL1 P00519 1/20 0.46
▸ SRC P12931 1/20 0.46
▸ MTOR P42345 1/20 0.46
▸ PRKDC P78527 1/20 0.46
▸ PIK3R1 P27986 1/20 0.38
▸ USP2 O75604 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9884100 0.91 PIK3CG (1.00) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL9884101 0.85 PIK3CG (0.90) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL9884102 0.83 PIK3CG (0.85) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL28392472 0.82 PIK3CG (0.69) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL9884074 0.81 PIK3CG (0.83) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL9884069 0.81 PIK3CG (0.73) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL21769549 0.81 PIK3CD (0.59) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL9884073 0.81 PIK3CG (0.82) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL9884089 0.81 PIK3CG (0.81) PIK3CGPIK3CDPIK3CAPIK3CBABL1
SCHEMBL9884087 0.81 PIK3CG (0.81) PIK3CGPIK3CDPIK3CAPIK3CBABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3613743-A1 PROCESSES FOR THE PREPARATION OF 1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE DERIVATIVES Intellikine, LLC (US) 2020-02-26 — — EP disclosed
Send feedback